COMMUNIQUÉS West-GlobeNewswire

Northwestern Memorial Hospital Earns U.S. News Honor Roll Recognition for 15th Consecutive Year
04/08/2026
Multiple Northwestern Medicine hospitals achieved national specialty rankings, top regional placements and high-performing distinctions across key areas of care CHICAGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- For the 15 th [...]
Amae Health Partners with Google Health Enterprise to Bring Wearable Data Integration to the Treatment of Complex Mental Health Conditions
04/08/2026
This collaboration reinforces Amae Health's precision psychiatry model, bringing the same level of measurement and precision to severe mental illness that is traditionally applied to physical healthcare SAN FRANCISCO, [...]
H1 Partners with Novo Nordisk to Scale AI-Driven Clinical Development
04/08/2026
Partnership builds on Novo Nordisk’s AI and digital foundation to enhance clinical trial design and execution through AI-enabled workflows and insights NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- H1 today announced a [...]
RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties
04/08/2026
Glen Rock, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases [...]
Capra Biosciences Advances Domestic Manufacturing of Essential Medicines with Continued HHS Support
04/08/2026
Follow-on investment builds on prior work to advance seven pharmaceutical ingredients toward commercial-scale domestic production STERLING, Va., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Capra Biosciences, Inc., a [...]
Integrity Urgent Care Clinic Opens in Murphy, Texas
04/08/2026
Murphy’s newest urgent care clinic offers accessible, high-quality health care you can count on Key facts of this press release: Integrity Urgent Care opened a clinic in Murphy, Texas, on Aug. 3, 2026 New Murphy clinic [...]
Integrity Urgent Care Clinic Opens in Conroe, Texas
04/08/2026
Conroe’s newest urgent care clinic offers accessible, high-quality health care you can count on Key facts of this press release: Integrity Urgent Care opened a clinic in Conroe, Texas, on Aug. 3, 2026 New Conroe clinic [...]
Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation
04/08/2026
Discussion explores how combining complementary payload technologies may unlock new therapeutic opportunities while reinforcing the versatility of Akari's proprietary PH1 spliceosome-modulating payload platform Access [...]
Amplia Signs Collaboration Agreement With Lilly, Evaluating Narmafotinib Plus Lilly’s Kras G12C Inhibitor, Olomorasib, in Non-small Cell Lung Cancer
04/08/2026
HIGHLIGHTS Amplia has executed a Clinical Trial Collaboration & Supply Agreement (CTCSA) with Eli Lilly & Company, to evaluate the Company’s investigational FAK inhibitor narmafotinib in combination with Lilly’s [...]
Cannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA Conference
04/08/2026
VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”), a developer of marijuana and alcohol breath testing [...]
Leads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases
04/08/2026
-- First‑in‑human trial of Oblenio’s sole asset, a CD19×BCMA×CD3 tri‑specific T‑cell engager, moves forward to rapidly generate broad proof of concept -- NANJING, China, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads [...]
Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases [...]
CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®
04/08/2026
NTAP Designation Expected to Support Medicare Patient Access, Treatment Center Economics and Commercial Adoption CLEVELAND, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage [...]
Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
04/08/2026
First module of the rolling NDA for QTORIN™ rapamycin for microcystic lymphatic malformations submitted to FDA, with completion of the NDA submission on track for the second half of 2026 Preparing for a planned [...]
Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile
04/08/2026
WAKIX® Net Revenue Grew 30% Year over Year to $261.3 Million for Second Quarter 2026; Estimated Average Patients Increased 450 to 8,950; Reiterates 2026 WAKIX Net Revenue Guidance of $1.0 Billion to $1.04 Billion Phase [...]
Tecan schedules conference call on August 11th to discuss half year 2026 financial results
04/08/2026
Männedorf, Switzerland, August 4, 2026 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2026 on Tuesday, August 11th, 2026, at 09:00 [...]
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
04/08/2026
New agreement builds on commercialization and development of precision-fermented dairy proteins and enzymes while reinforcing Dyadic's diversified commercialization strategy JUPITER, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE [...]
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/08/2026
NEW HAVEN, Conn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on August 1, 2026, Invivyd granted ten newly hired non-executive employees options to purchase an aggregate of 277, [...]
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
04/08/2026
-- U.S. launch of IMCIVREE ® (setmelanotide) for acquired hypothalamic obesity (HO) starts strong with more than 400 patient start forms since FDA approval as of June 30, 2026 -- -- Second quarter 2026 net product [...]

Pages